MarketPeel
Insider Trading Intelligence
AW

Arsani William

DSGN
DIRECTOR · DESIGN THERAPEUTICS, INC. · CIK 0001848372
FILING MIX · LIFETIME75%/25%
BUYS
15
SELLS
5
TOTAL VALUE
$40.88M
COMPANIES
1
ACTIVE SINCE
Mar 2021
HOLDINGS NOW
2,655,000
AVG SELL PX
$4.66
TRADE KIND
SHOWING 20 / 20
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
8 backtested trades · 8 horizons · 5 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Arsani William, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d8+75.00%+1.00%+1.10%-0.10%-0.53%
14d8+62.50%+2.91%+1.54%+1.37%+0.92%
30d8+25.00%+1.41%+0.07%+1.34%+9.06%
60d8+0.00%-1.91%-0.69%-1.22%-1.77%
90d8+12.50%+10.49%+2.88%+7.61%+3.21%
180d8+37.50%+25.77%+7.01%+18.75%+11.43%
1y8(2 pending)+50.00%+24.19%+12.19%+12.01%+10.19%
2y8(3 pending)+40.00%+7.06%+25.28%-18.21%-86.07%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
DSGN · 2,655,000 shares · as of Aug 13, 2025
0750,0001,500,0002,250,0003,000,0002022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
FLOW · 15 buys / 5 sellsCOVERAGE · 19 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
DSGN
DESIGN THERAPEUTICS, INC.
SALE
217,627$5.25$1.14M1,000,000Aug 13, 2025Aug 14, 2025View →
DSGN
DESIGN THERAPEUTICS, INC.
SALE
345,000$5.25$1.81M2,655,000Aug 13, 2025Aug 14, 2025View →
DSGN
DESIGN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
19,00019,000Jun 10, 2025Jun 12, 2025View →
DSGN
DESIGN THERAPEUTICS, INC.
SALE
814,874$4.25$3.46M0Aug 9, 2024Aug 12, 2024View →
DSGN
DESIGN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
19,00019,000Jun 13, 2024Jun 17, 2024View →
DSGN
DESIGN THERAPEUTICS, INC.
PURCHASE
1,960,000$2.44$4.78M3,000,000Aug 29, 2023Aug 30, 2023View →
DSGN
DESIGN THERAPEUTICS, INC.
PURCHASE
275,000$2.15$591.3K1,040,000Aug 28, 2023Aug 30, 2023View →
DSGN
DESIGN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,00015,000May 31, 2023Jun 2, 2023View →
DSGN
DESIGN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,00015,000Jun 15, 2022Jun 16, 2022View →
DSGN
DESIGN THERAPEUTICS, INC.
PURCHASE
25,000$18.99$474.7K2,797,501Mar 21, 2022Mar 22, 2022View →
DSGN
DESIGN THERAPEUTICS, INC.
PURCHASE
40,000$15.45$618.0K2,772,501Aug 31, 2021Sep 2, 2021View →
DSGN
DESIGN THERAPEUTICS, INC.
PURCHASE
700,000$20.00$14.00M700,000Mar 30, 2021Sep 6, 2023View →
DSGN
DESIGN THERAPEUTICS, INC.
PURCHASE
814,874814,874Mar 30, 2021Sep 6, 2023View →
DSGN
DESIGN THERAPEUTICS, INC.
PURCHASE
1,217,6271,217,627Mar 30, 2021Sep 6, 2023View →
DSGN
DESIGN THERAPEUTICS, INC.
SALE
1,984,7330Mar 30, 2021Mar 31, 2021View →
DSGN
DESIGN THERAPEUTICS, INC.
PURCHASE
814,8742,032,501Mar 30, 2021Mar 31, 2021View →
DSGN
DESIGN THERAPEUTICS, INC.
PURCHASE
1,217,6271,217,627Mar 30, 2021Mar 31, 2021View →
DSGN
DESIGN THERAPEUTICS, INC.
SALE
1,328,2450Mar 30, 2021Mar 31, 2021View →
DSGN
DESIGN THERAPEUTICS, INC.
PURCHASE
700,000$20.00$14.00M2,732,501Mar 30, 2021Mar 31, 2021View →
DSGN
DESIGN THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,00015,000Mar 25, 2021Mar 26, 2021View →
Other insiders · DSGN
Loading peer insiders…
About this filer
CIK 0001848372
ROLE
Director
PRIMARY
DSGN
COMPANIES
1
ACTIVE SINCE
Mar 2021
MARKETPEEL · /INSIDER/0001848372DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback